146 related articles for article (PubMed ID: 25939163)
1. HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.
Gower WR; Risch RM; Godellas CV; Fabri PJ
In Vitro Cell Dev Biol Anim; 1994 Mar; 30A(3):151-61. PubMed ID: 25939163
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.
Liu L; Aleksandrowicz E; Schönsiegel F; Gröner D; Bauer N; Nwaeburu CC; Zhao Z; Gladkich J; Hoppe-Tichy T; Yefenof E; Hackert T; Strobel O; Herr I
Cell Death Dis; 2017 Oct; 8(10):e3064. PubMed ID: 28981109
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
Yao Y; Yao QY; Xue JS; Tian XY; An QM; Cui LX; Xu C; Su H; Yang L; Feng YY; Hao CY; Zhou TY
Toxicol Appl Pharmacol; 2020 Aug; 401():115118. PubMed ID: 32619553
[TBL] [Abstract][Full Text] [Related]
4. Functional glucocorticoid receptor modulates pancreatic carcinoma growth through an autocrine loop.
Norman J; Franz M; Schiro R; Nicosia S; Docs J; Fabri PJ; Gower WR
J Surg Res; 1994 Jul; 57(1):33-8. PubMed ID: 7518883
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
7. Suppression of rat mammary tumor cell growth in vitro by glucocorticoids requires serum proteins. Characterization of wild type and glucocorticoid-resistant epithelial tumor cells.
Webster MK; Guthrie J; Firestone GL
J Biol Chem; 1990 Mar; 265(9):4831-8. PubMed ID: 2318865
[TBL] [Abstract][Full Text] [Related]
8. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced pancreatic-hepatic trans-differentiation in a human cell line in vitro.
Fairhall EA; Leitch AC; Lakey AF; Probert PME; Richardson G; De Santis C; Wright MC
Differentiation; 2018; 102():10-18. PubMed ID: 29857331
[TBL] [Abstract][Full Text] [Related]
10. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid.
Lui WY; Chi CW; Chang YF; Chu HW; Hsieh CC; Yin PH; Liu TY; Ou YR; P'eng FK
Anticancer Res; 2002; 22(3):1413-22. PubMed ID: 12168818
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucocorticoid receptor antagonist RU 38486 on acute glucocorticoid-induced insulin resistance in rat adipocytes.
Ishizuka T; Nagashima T; Kajita K; Miura A; Yamamoto M; Itaya S; Kanoh Y; Ishizawa M; Murase H; Yasuda K
Metabolism; 1997 Sep; 46(9):997-1002. PubMed ID: 9284886
[TBL] [Abstract][Full Text] [Related]
13. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
14. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
Jung DE; Kim JM; Kim C; Song SY
Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
19. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.
Zhang M; Fan HY; Li SC
Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
